Resources
News

Whistleblower Attorney Says Shield 'Came Up With' FCA Scheme

March 28, 2018 Media Mentions

Verrill Dana attorney Paul Shaw was recently quoted in an online article featured in the publication Law360 entitled "Whistleblower Attorney Says Shield 'Came Up With' FCA Scheme." The article discusses a recent whistleblower case in which employees of the medical device company Coloplast accused the company of organizing an alleged kickback scheme.

The three whistleblowers involved in the Coloplast case are fighting to keep Shield Medical Inc., a California medical device company, in their False Claims Act lawsuit. The relators of the lawsuit are represented by Verrill Dana attorneys Paul Shaw, Cecilie MacIntyre, and Joanna Bowers.

According to the article, Paul Shaw argued "that former Coloplast Corp. employees sued Shield, among numerous other incontinence-related medical supplies and distributors, because the California company played a major role in an alleged kickback scheme in which Coloplast gave illicit discounts to partners who converted customers to Coloplast."

Read "Whistleblower Attorney Says Shield 'Came Up With' FCA Scheme" on Law360.com.

Firm Highlights

News

High-Profile Former U.S. Department of Justice Prosecutor, David Lazarus, Joins Verrill’s Health Care and Life Sciences Practice

(November 29, 2021) – Verrill is pleased to welcome David Lazarus to the firm’s Boston office as a Partner in its nationally recognized Health Care & Life Sciences Group. Lazarus is a former Department...

Publication/Podcast

Massachusetts Health Care Bill Makes Several Significant Changes

While you were celebrating the New Year, Governor Baker signed Chapter 260 of the Acts of 2020, an “Act promoting a resilient health care system that puts patients first,” the result of the Legislature’s...

Publication/Podcast

HHS Confirms Providers’ Right to 340B Discount Pricing for Contract Pharmacies

As a holiday gift to providers, the U.S. Department of Health and Human Services (HHS) General Counsel recently issued a strongly worded Advisory Opinion indicating that federal law requires drug manufacturers to deliver covered...

Publication/Podcast

Fraud and Abuse Investigations Handbook for the Health Care Industry, Second Edition.

Health care attorney Paul Shaw co-authored Fraud and Abuse Investigations Handbook for the Health Care Industry, Second Edition with Robert Griffith, published by the American Health Law Association (AHLA). Paul and Robert provide legal...

News

65 Verrill Attorneys Recognized by Best Lawyers® 2022, Including Eight Named Lawyers of the Year

(August 31, 2021) – 65 Verrill attorneys were recognized as "Best Lawyers" by Best Lawyers® 2022 , including 8 attorneys named “Lawyer of the Year,” a distinguished recognition for only a single lawyer in...

Publication/Podcast

The Regulatory Sprint is Over - What’s at the Finish Line Under the New Stark and AKS Final Rules?

The U.S. Department of Health and Human Services (HHS) completed its “Regulatory Sprint” by finalizing changes to regulations pertaining to two federal fraud and abuse laws. On December 2, 2020, the Centers for Medicare...

Publication/Podcast

Breaking: OSHA Releases Emergency Temporary Standard for Employers with 100 or More Employees

Blog

Breaking: OSHA Releases Emergency Temporary Standard for Employers with 100 or More Employees

IMPORTANT UPDATE- 11-11-21 The federal court of appeals for the Fifth Circuit has suspended OSHA’s Temporary Emergency Standard in response to a lawsuit filed last Friday by a number of Plaintiffs, which included the...

News

Verrill's Strategic Growth in Key Areas Shared in Mainebiz

On Monday, November 15th Verrill was listed as a Maine law firm who is innovating ways to hire talent in the Mainebiz article "Remote Work Changes Hiring Strategies for Some Maine Law Firms." The...

Publication/Podcast

340B Providers Get Partial Relief from New Dispute Resolution Regulation

1. 340B ADR Process Established At long last, more than ten years after Congress directed it to do so, HHS has finalized an alternative dispute resolution (“ADR”) process for both providers and pharmaceutical manufacturers...

Contact Verrill at (855) 307 0700